October 18, 2016
Mobile clinical trials company Science 37, which connects willing individuals to researchers so they can participate in trials from their homes, has raised $31 million in Series B funding. Previously, the company raised $6.5 million.
The round was led by Redmile Group, with participation from Lux Capital and Sanofi Genzyme BioVentures, the latter of which will also provide Science 37 with...
June 13, 2016
Two of the biggest IPOs in digital health lately have come out of the wearable and telehealth spaces. But those aren't the spaces at least two seasoned digital health investors are most excited about. At BIO 2016 in San Francisco last week, Casper de Clerq, a general partner at Norwest Venture Partners, and Dr. Lucian Iancovici, a general partner at dRx Capital, Qualcomm and Novartis' joint...
October 21, 2015
Los Angeles-based mobile clinical trials company Science 37 has raised $6.5 million from Lux Capital and dRx Capital, a joint venture of Qualcomm and Novartis that launched in January.
The funding will help the company develop and roll out its novel clinical trial operating model, which uses mobile technology to allow patients to participate in the trial from their homes. The company draws on ...